Clinical Trial Update: The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tulsi extract for managing oral mucositis in head and neck cancer patients undergoing radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Tulsi extract (Ocimum sanctum extract)

Snippet

Sponsor: Cairo University | Conditions: Stomatitis | Phase 2 | Status: UNKNOWN